Follow
Clinical Trials
Clinical Trials: A clinical trial involves research participants. It follows a pre-defined plan or protocol to evaluate the effects of a medical or behavioral intervention on health outcomes. Clinical trials are done to determine whether new drugs or treatments are safe and effective. By taking part in clinical trials, participants not only play a more active role in their own health care, but they also can access experimental treatments and help others by contributing to medical research.
JAN 18, 2024 | 10:00 AM
In 2020, American Cancer Society released an updated cervical cancer screening guideline calling for primary human papillomavirus (HPV) screening as the preferred strategy. Utility of HPV pr...
NOV 14, 2023 | 6:00 AM
C.E. CREDITS
It is over half a century since haemoglobin A1c (HbA1c) was recognised by medical professionals; the importance of HbA1c to the long term health of people with diabetes was clearly demonstra...
NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 10, 2023 | 10:00 AM
C.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
OCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
SEP 28, 2023 | 7:00 AM
Webinars will be available for unlimited on-demand viewing after live event. Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the AS...
AUG 10, 2023 | 8:00 AM
C.E. CREDITS
Antibody therapeutics is a fast-growing market boosted by developments in bispecific antibodies and in newly emerging tetra-specific antibodies. With the ability to recruit a combination of...
JUL 26, 2023 | 3:10 PM
C.E. CREDITS
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
MAY 02, 2023 | 8:00 AM
C.E. CREDITS
Abstract Learning Objectives Define a tertiary lymphoid structure in human cancer Describe the tumor microenvironment factors that influence the formation of tertiary lymphoid structures Ide...
APR 28, 2023 | 12:00 AM
C.E. CREDITS
Heparin-Induced Thrombocytopenia (HIT): Practical Aspects of Clinical and Laboratory Diagnosis Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exp...
APR 25, 2023 | 8:00 AM
C.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm o...
APR 24, 2023 | 12:00 AM
C.E. CREDITS
Coagulation tests are useful in the diagnosis and management of bleeding or thrombotic disorders. The majority of hospital and reference laboratories perform routine coagulation testing such...
APR 11, 2023 | 8:00 AM
C.E. CREDITS
Date: April 11, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Duchenne muscular dystrophy is caused by mutations in the dystrophin encoding DMD gene that disrupt the reading frame. M...
MAR 28, 2023 | 3:30 AM
C.E. CREDITS
Date: March 28, 2023 Time: 3:30am (PDT), 6:30am (EDT), 12:30pm (CEST) Biofluid-based neurological biomarkers have shown promise in helping to improve diagnostic accuracy, predict disease pro...
MAR 23, 2023 | 8:00 AM
Date: March 23, 2023 Time: 8:00am (PDT), 11:00am (EDT), 8:00pm (CEST) Across clinical oncology applications, from molecular testing to cancer research the ability to identify potentially act...
MAR 08, 2023 | 6:00 AM
C.E. CREDITS
Black Americans have an increased risk for age-related cognitive decline and Alzheimer's disease (AD) compared to other ethnic and racialized groups. However, risk factors for age-relate...
MAR 08, 2023 | 6:00 AM
C.E. CREDITS
Natural Language Processing is experiencing a phenomenal capabilities acceleration since the introduction of Large Language Models (LLMs). This success stems in part from the ability to inge...
FEB 22, 2023 | 1:00 PM
Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exposure. This webinar presentation will discuss the pathogenesis, incidence, clinical...
FEB 22, 2023 | 5:30 AM
C.E. CREDITS
Ninety percent of therapeutic agents reaching clinical trial fail to reach entry to market, with safety concerns being a major cause for failures in phase I and II clinical trials. Drug-indu...
MAR 08, 2023 | 6:00 AM
C.E. CREDITS
Natural Language Processing is experiencing a phenomenal capabilities acceleration since the introduction of Large Language Models (LLMs). This success stems in part from the ability to inge...
FEB 22, 2023 | 1:00 PM
Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exposure. This webinar presentation will discuss the pathogenesis, incidence, clinical...
FEB 22, 2023 | 5:30 AM
C.E. CREDITS
Ninety percent of therapeutic agents reaching clinical trial fail to reach entry to market, with safety concerns being a major cause for failures in phase I and II clinical trials. Drug-indu...